Lifestyle and rehabilitation in long term illness

Cancer rehabilitation

Cancer causes 20% of deaths in the European Region and more than 3 million new cases and 1.7 million deaths are reported each year. Cancer survivors are at increased risk for developing secondary tumors as well as other chronic diseases as osteoporosis, diabetes and cardiovascular diseases. This means an increased burden on the entire continuum of care and the societal costs. For many of these diseases, lifestyle factors affect the risk. Thus, cancer patients as well as cancer survivors represent an important target population for lifestyle interventions given their increased risk and ever-increasing numbers. The distinguishing feature of the most projects ongoing and planned in this research group is that they are cross-disciplinary randomized controlled intervention studies focusing on lifestyle (e.g. physical exercise, stress management, nutrition) in cancer patients.In addition, the projects will generate valid, high quality data covering different areas, from basic biomedical data to patient related outcomes (PROs), i.e. from “bench to bedside”.

Ongoing project

Phys-Can

 – Physical training and cancer. Effects and understanding of mechanisms for prevent and minimizing cancer related fatigue, improve quality of life and disease outcome

 This project is a collaboration between researchers from Uppsala University, Lund University and Linköping University in Sweden, the University of Agder and Bergen in Norway,University of Copenhagen, Denmark, The Netherlands Cancer Institute, VU University Medical Centre, Amsterdam, University of Amsterdam and University of Leeds, UK. 

Other ongoing external founded projects

·How can health care reduce stress-related problems in patients with breast cancer - a randomized intervention study

·Health-related quality of life, patient satisfaction and return to work among breast cancer patients – a long-term follow-up study


Psychosocial genetics

Modern gene technology has made it possible to identify individuals with an increased risk for diseases, and rapid development in gene technology is expected to have a substantial impact on treatment and care in the future. While genetic research makes rapid progress, empirical studies of risk perception, psychological consequences and behaviour change in persons at risk, as well as knowledge about the clinician’s understanding of - and adaptability to - the challenges that the new technology represent, are still sparse. These aspects are targeted within the studies in this research group

Ongoing projects 

·Prenatal diagnosis and information

·Toward Individualized Genetic Counselling in Hereditary Cancer - Financed by the Swedish cancer Society

Kontakt

Forskningsledare

Karin Nordin
Professor

018-471 3487
E-post